University of michigan phase 1/2 assessment in kidney cancer

Ended Cooperative Agreement Awarded Last action

Award ID
W81XWH2120024
Recipient
Awarding agency
Obligated
$1,389,061

Award facts

Assistance listing
12.420 Military Medical Research and Development
Completion date
Originally
Place of performance
Ann Arbor, MI 48109, USA

Award details come from USAspending.gov.

Transactions

Action Obligated Date
Amendment Phase 1/2 assessment in kidney cancer therapeutics (UMPAKT) DE-obligate funds to close award per section 711 of the national defense authorization act (NDAA)… -$14,939
Amendment Extends the period of performance by one year at an additional cost to the government of $468,000 per the recipient S email 20 june 2022. Technical and… $468,000
Amendment Exercises the option.2. Provides funding for the exercised option year in the amount of $468,000 via PR 0011637972-0002.3. Updates items a.5.II, a.7, a.10.VI,… $468,000
Amendment This administrative modification establishes the line item for the option year. Division I items a.4, a.5.II, and a.6. Are updated. $0
Original award $468,000

Quick answers

Who received award W81XWH2120024?

W81XWH2120024 was awarded to Regents Of The University Of Michigan by Defense Health Agency (Department of Defense) on September 15, 2021.

How much is award W81XWH2120024 worth?

$1,389,061 has been obligated on W81XWH2120024.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login